Personal information

Countries

China

Activities

Collapse all

Education and qualifications (3)

University of Edinburgh: Edinburgh, GB

2022 to 2025 | PhD (Centre for Regenerative Medicine)
Education
Source: Self-asserted source
Zeyu Wang

Xiangya Hospital Central South University: Changsha, Hunan, CN

2019 to 2022 | Master of Surgery (Department of Neurosurgery)
Education
Source: Self-asserted source
Zeyu Wang

Central South University Xiangya School of Medicine: Changsha, Hunan, CN

2014 to 2019 | MBBS
Education
Source: Self-asserted source
Zeyu Wang

Funding (2)

Edinburgh Doctoral College Scholarship

Source: Self-asserted source
Zeyu Wang

the Fundamental Research Funds for the Central Universities of Central South University

Award
Central South University (Changsha, CN)
GRANT_NUMBER:

2021zzts1027
Source: Self-asserted source
Zeyu Wang

Works (16)

Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma

Clinical Immunology
2024-01 | Journal article
DOI: 10.1016/j.clim.2023.109802
Part of ISSN: 1521-6616
Contributors: Xisong Liang; Zeyu Wang; Ziyu Dai; Jian Liu; Hao Zhang; Jie Wen; Nan Zhang; Jian Zhang; Peng Luo; Zaoqu Liu et al.
Source: Self-asserted source
Zeyu Wang

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma

Frontiers in Immunology
2023-04-12 | Journal article
DOI: 10.3389/fimmu.2023.894853
Part of ISSN: 1664-3224
Contributors: Zeyu Wang; Ziyu Dai; Hao Zhang; Xisong Liang; Xun Zhang; Zhipeng Wen; Peng Luo; Jian Zhang; Zaoqu Liu; Mingyu Zhang et al.
Source: Self-asserted source
Zeyu Wang

Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy

Cell Proliferation
2023-03 | Journal article
DOI: 10.1111/cpr.13376
Part of ISSN: 0960-7722
Part of ISSN: 1365-2184
Contributors: Zeyu Wang; Ziyu Dai; Hao Zhang; Nan Zhang; Xisong Liang; Luo Peng; Jian Zhang; Zaoqu Liu; Yun Peng; Quan Cheng et al.
Source: Self-asserted source
Zeyu Wang

Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy

Cancer Gene Therapy
2022-12-09 | Journal article
DOI: 10.1038/s41417-022-00569-9
Part of ISSN: 0929-1903
Part of ISSN: 1476-5500
Contributors: Xisong Liang; Zeyu Wang; Ziyu Dai; Hao Zhang; Jian Zhang; Luo Peng; Zaoqu Liu; Zhixiong Liu; Kui Yang; Quan Cheng et al.
Source: Self-asserted source
Zeyu Wang

The role of lipocalin 2 in brain injury and recovery after ischemic and hemorrhagic stroke

Frontiers in Molecular Neuroscience
2022-09-15 | Journal article
DOI: 10.3389/fnmol.2022.930526
Part of ISSN: 1662-5099
Contributors: Jingwei Zhang; Zeyu Wang; Hao Zhang; Shuwang Li; Jing Li; Hongwei Liu; Quan Cheng
Source: Self-asserted source
Zeyu Wang

JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer

Frontiers in Immunology
2022-07-11 | Journal article
DOI: 10.3389/fimmu.2022.875786
Part of ISSN: 1664-3224
Contributors: Xisong Liang; Hao Zhang; Zeyu Wang; Xun Zhang; Ziyu Dai; Jian Zhang; Peng Luo; Longbo Zhang; Jason Hu; Zaoqu Liu et al.
Source: Self-asserted source
Zeyu Wang

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways.

Frontiers in cell and developmental biology
2022-02-17 | Journal article
DOI: 10.3389/fcell.2022.740822
PMID: 35252165
PMC: PMC8891612
Source: Self-asserted source
Zeyu Wang

The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.

Frontiers in immunology
2021-09-13 | Journal article
DOI: 10.3389/fimmu.2021.731751
PMID: 34603309
PMC: PMC8482424
Source: Self-asserted source
Zeyu Wang
grade
Preferred source (of 2)‎

Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation

Cell Proliferation
2021-03 | Journal article
DOI: 10.1111/cpr.12988
Contributors: Zeyu Wang; Guanhua Su; Ziyu Dai; Ming Meng; Hao Zhang; Fan Fan; Zhengzheng Liu; Longbo Zhang; Nathaniel Weygant; Fengqiong He et al.
Source: check_circle
Crossref

The adaptive transition of glioblastoma stem cells and its implications on treatments.

Signal transduction and targeted therapy
2021-03-23 | Journal article
DOI: 10.1038/s41392-021-00491-w
PMID: 33753720
Source: Self-asserted source
Zeyu Wang

Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents' Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma.

Frontiers in immunology
2021-01-01 | Journal article
DOI: 10.3389/fimmu.2021.747408
PMID: 35126346
PMC: PMC8807564
Source: Self-asserted source
Zeyu Wang

Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas.

Frontiers in cell and developmental biology
2021-01-01 | Journal article
DOI: 10.3389/fcell.2021.754873
PMID: 35223862
PMC: PMC8864229
Source: Self-asserted source
Zeyu Wang

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma.

Frontiers in immunology
2021-01-01 | Journal article
DOI: 10.3389/fimmu.2021.756606
PMID: 35116021
PMC: PMC8805082
Source: Self-asserted source
Zeyu Wang

Pentraxin 3 Promotes Glioblastoma Progression by Negative Regulating Cells Autophagy.

Frontiers in cell and developmental biology
2020-08-26 | Journal article
DOI: 10.3389/fcell.2020.00795
PMID: 32984316
PMC: PMC7479068
Source: Self-asserted source
Zeyu Wang

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.

Frontiers in immunology
2020-08-18 | Journal article
DOI: 10.3389/fimmu.2020.01757
PMID: 33013829
PMC: PMC7461825
Source: Self-asserted source
Zeyu Wang

PDIA4: The basic characteristics, functions and its potential connection with cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2019-11-30 | Journal article
DOI: 10.1016/j.biopha.2019.109688
PMID: 31794946
Source: Self-asserted source
Zeyu Wang

Peer review (7 reviews for 3 publications/grants)

Review activity for Cancer letters. (5)
Review activity for Genomics. (1)
Review activity for Medical oncology. (1)
How many people are using ORCID?